These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 15273094

  • 1. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH, Houck HJ.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [Abstract] [Full Text] [Related]

  • 2. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH, Houck H.
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.
    Cilli F, Aydemir S, Tunger A.
    J Chemother; 2006 Feb; 18(1):27-32. PubMed ID: 16572890
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS, Fritsche TR, Jones RN.
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [Abstract] [Full Text] [Related]

  • 5. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR, Yim J, Raut A, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [Abstract] [Full Text] [Related]

  • 6. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 7. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM, Giddey M, Vouillamoz J, Moreillon P.
    Int J Antimicrob Agents; 2010 May 18; 35(5):451-6. PubMed ID: 20185277
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.
    Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T.
    Antimicrob Agents Chemother; 2001 Jun 18; 45(6):1737-42. PubMed ID: 11353619
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
    Credito K, Lin G, Appelbaum PC.
    Antimicrob Agents Chemother; 2007 Apr 18; 51(4):1504-7. PubMed ID: 17220402
    [Abstract] [Full Text] [Related]

  • 11. Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes.
    Barber KE, Werth BJ, Ireland CE, Stone NE, Nonejuie P, Sakoulas G, Pogliano J, Rybak MJ.
    J Antimicrob Chemother; 2014 Nov 18; 69(11):3006-10. PubMed ID: 24990867
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
    Snydman DR, McDermott LA, Jacobus NV.
    J Chemother; 2005 Dec 18; 17(6):614-21. PubMed ID: 16433191
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M, Grupo VIRA.
    Enferm Infecc Microbiol Clin; 2010 Jan 18; 28(1):13-6. PubMed ID: 19406529
    [Abstract] [Full Text] [Related]

  • 15. The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species.
    Richter SS, Kealey DE, Murray CT, Heilmann KP, Coffman SL, Doern GV.
    J Antimicrob Chemother; 2003 Jul 18; 52(1):123-7. PubMed ID: 12805265
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD, Citron DM.
    Diagn Microbiol Infect Dis; 2010 Apr 18; 66(4):441-4. PubMed ID: 20226335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M, Aguilar L, Sevillano D, Giménez MJ, Alou L, González N, Cafini F, Cleeland R, Prieto J.
    Int J Antimicrob Agents; 2011 Apr 18; 37(4):332-8. PubMed ID: 21388792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.